Impugan

Furosemide, the active ingredient in Impugan, is a loop diuretic presented as an oral tablet for oral use. It treats edema associated with congestive heart failure, renal disease, hypertension and pulmonary edema. GNH USA supplies Impugan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Furosemide is a loop diuretic used to manage conditions involving fluid overload. - Edema associated with congestive heart failure: reduces excess fluid accumulation and improves symptoms. - Edema due to renal disease: promotes diuresis to alleviate swelling. - Hypertension: lowers blood pressure by decreasing plasma volume. - Pulmonary edema: facilitates rapid removal of fluid from the lungs.

Furosemide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased urination - Electrolyte imbalances (e.g., low potassium, sodium) - Dizziness or light‑headedness - Headache - Dehydration - Muscle cramps

Serious or Rare Side Effects: - Severe dehydration - Acute kidney injury - Ototoxicity (hearing loss or ringing) - Severe allergic reactions such as anaphylaxis - Hyperuricemia leading to gout attacks - Blood dyscrasias (e.g., agranulocytosis).

When prescribing Impugan, several safety considerations should be observed. - Renal function monitoring: assess kidney function before and during therapy. - Electrolyte monitoring: regularly check serum potassium, sodium and magnesium levels. - Concomitant NSAIDs: avoid or use with caution as they may diminish diuretic efficacy. - Diabetes management: monitor blood glucose because diuresis can affect control. - Gout risk: be aware of potential increase in uric acid levels. - Pregnancy and lactation: use only if clearly needed; safety not established. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Furosemide interacts with several drug classes that may require dose adjustment or monitoring.

Major Interactions (Avoid): - Aminoglycoside antibiotics: increased risk of ototoxicity. - High‑dose NSAIDs: may blunt diuretic response and worsen renal function. - Lithium: reduced clearance can raise lithium toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may potentiate hypotension and renal impairment. - Antidiabetic agents: diuresis may affect glucose control. - Other diuretics: additive electrolyte disturbances.